Precise and Personalized Medicine

I do not know you, but my favorite gift was designed for me. This may be engraved on a calendar full of jewelry of my name and pictures of my family. In a nutshell, these items are most important as they are well thought out. The stage of precision medical care is mentally too simple, but the technology to provide this medical treatment is very complicated. Every year, the ability to locate the problem and tweak the treatment will rapidly increase.

The interest in "accurate" or "personalized" medical concepts is increasing more and more recent President Obama 's efforts on large - scale genomics stimulated him. There is considerable enthusiasm in many areas, but this movement is not a soundless opponent. In the recent Los Angeles Times feature article, "Why Genome wide test damage exceeds its help?" (Http://www.latimes.com/opinion/op-ed/la-oe-welch-problems- predictive) - medicine - 20150428 - story.html), Drs. Medical professor Dartmouth Medical School medical professor H. Gilbert Welch and Washington University bioethics and humanities professor Wylie Burke believe that investing in genomics in the way President Obama said is a misleading approach There is more noise than the signal, meaning there are too many variables, too many combinations of genomic data and clinical data to detect meaningful patterns.

In this article we will explain this discussion by reviewing three major brand remodeling events in modern genomics: a recent shift from personalization to precision medicine, transition from precision medical care to precision and health, and First transition from precision health to healthy genomics By giving traditional medical goals and individualized medicine, as genetic medicine regains the application of human genetics from eugenics ideology bias, morality is We emphasize the responsibilities of individual patients, so that each of these transformations in genomics emphasizes a variety of ethical commitments. As the venue matures, monitoring is very important.

Why is it important to transition from 'personalized medicine' to 'accurate health' and 'healthy genomics'?